Does sodium nitroprusside decrease the incidence of atrial fibrillation after myocardial revascularization? A pilot study

Creative Commons License

Cavolli R., Kaya K., Aslan A., Emiroglu O., Erturk S., Korkmaz O., ...More

CIRCULATION, vol.118, no.5, pp.476-481, 2008 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 118 Issue: 5
  • Publication Date: 2008
  • Doi Number: 10.1161/circulationaha.107.719377
  • Journal Name: CIRCULATION
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.476-481
  • Keywords: myocardial revascularization, atrial fibrillation, sodium nitroprusside, ARTERY-BYPASS SURGERY, CARDIAC-SURGERY, CARDIOPULMONARY BYPASS, RANDOMIZED-TRIAL, NITRIC-OXIDE, AMIODARONE, PREVENTION, PROPHYLAXIS, PLACEBO, COMBINATION
  • Ankara University Affiliated: Yes

Abstract

Background - Atrial fibrillation ( AF) often occurs after coronary artery bypass grafting and can result in increased morbidity and mortality. In the present pilot study, our aim was to investigate whether sodium nitroprusside (SNP), as a nitric oxide donor, can reduce the frequency of post - coronary artery bypass grafting AF.